Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Mem Inst Oswaldo Cruz ; 115: e190389, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32074167

RESUMO

BACKGROUND: Chagas disease, which is caused by the protozoan Trypanosoma cruzi, is endemic to Latin America and mainly affects low-income populations. Chemotherapy is based on two nitrocompounds, but their reduced efficacy encourages the continuous search for alternative drugs. Our group has characterised the trypanocidal effect of naphthoquinones and their derivatives, with naphthoimidazoles derived from ß-lapachone (N1, N2 and N3) being the most active in vitro. OBJECTIVES: In the present work, the effects of N1, N2 and N3 on acutely infected mice were investigated. METHODS: in vivo activity of the compounds was assessed by parasitological, biochemical, histopathological, immunophenotypical, electrocardiographic (ECG) and behavioral analyses. FINDINGS: Naphthoimidazoles led to a decrease in parasitaemia (8 dpi) by reducing the number of bloodstream trypomastigotes by 25-50% but not by reducing mortality. N1 protected mice from heart injury (15 dpi) by decreasing inflammation. Bradycardia was also partially reversed after treatment with N1 and N2. Furthermore, the three compounds did not reverse hepatic and renal lesions or promote the improvement of other evaluated parameters. MAIN CONCLUSION: N1 showed moderate trypanocidal and promising immunomodulatory activities, and its use in combination with benznidazole and/or anti-arrhythmic drugs as well as the efficacy of its alternative formulations must be investigated in the near future.


Assuntos
Doença de Chagas/tratamento farmacológico , Naftoquinonas/uso terapêutico , Nitroimidazóis/uso terapêutico , Tripanossomicidas/uso terapêutico , Doença Aguda , Animais , Anti-Inflamatórios , Modelos Animais de Doenças , Eletrocardiografia , Masculino , Camundongos , Naftoquinonas/química , Nitroimidazóis/química , Parasitemia/tratamento farmacológico , Fatores de Tempo , Tripanossomicidas/química
2.
Mem. Inst. Oswaldo Cruz ; 110(4): 492-499, 09/06/2015. tab, graf
Artigo em Inglês | LILACS | ID: lil-748858

RESUMO

Nitroimidazoles exhibit high microbicidal activity, but mutagenic, genotoxic and cytotoxic properties have been attributed to the presence of the nitro group. However, we synthesised nitroimidazoles with activity against the trypomastigotes of Trypanosoma cruzi, but that were not genotoxic. Herein, nitroimidazoles (11-19) bearing different substituent groups were investigated for their potential induction of genotoxicity (comet assay) and mutagenicity (Salmonella/Microsome assay) and the correlations of these effects with their trypanocidal effect and with megazol were investigated. The compounds were designed to analyse the role played by the position of the nitro group in the imidazole nucleus (C-4 or C-5) and the presence of oxidisable groups at N-1 as an anion receptor group and the role of a methyl group at C-2. Nitroimidazoles bearing NO2 at C-4 and CH3 at C-2 were not genotoxic compared to those bearing NO 2 at C-5. However, when there was a CH3 at C-2, the position of the NO2 group had no influence on the genotoxic activity. Fluorinated compounds exhibited higher genotoxicity regardless of the presence of CH3 at C-2 or NO2 at C-4 or C-5. However, in compounds 11 (2-CH3; 4-NO2; N-CH2OHCH2Cl) and 12 (2-CH3; 4-NO2; N-CH2OHCH2F), the fluorine atom had no influence on genotoxicity. This study contributes to the future search for new and safer prototypes and provide.


Assuntos
Animais , Camundongos , Dano ao DNA/efeitos dos fármacos , Nitroimidazóis/química , Nitroimidazóis/toxicidade , Salmonella/efeitos dos fármacos , Trypanosoma cruzi/efeitos dos fármacos , Ensaio Cometa , Relação Dose-Resposta a Droga , Testes de Mutagenicidade , Relação Estrutura-Atividade
3.
Mem Inst Oswaldo Cruz ; 110(4): 492-9, 2015 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-26018452

RESUMO

Nitroimidazoles exhibit high microbicidal activity, but mutagenic, genotoxic and cytotoxic properties have been attributed to the presence of the nitro group. However, we synthesised nitroimidazoles with activity against the trypomastigotes of Trypanosoma cruzi, but that were not genotoxic. Herein, nitroimidazoles (11-19) bearing different substituent groups were investigated for their potential induction of genotoxicity (comet assay) and mutagenicity (Salmonella/Microsome assay) and the correlations of these effects with their trypanocidal effect and with megazol were investigated. The compounds were designed to analyse the role played by the position of the nitro group in the imidazole nucleus (C-4 or C-5) and the presence of oxidisable groups at N-1 as an anion receptor group and the role of a methyl group at C-2. Nitroimidazoles bearing NO2 at C-4 and CH3 at C-2 were not genotoxic compared to those bearing NO 2 at C-5. However, when there was a CH3 at C-2, the position of the NO2 group had no influence on the genotoxic activity. Fluorinated compounds exhibited higher genotoxicity regardless of the presence of CH3 at C-2 or NO2 at C-4 or C-5. However, in compounds 11 (2-CH3; 4-NO2; N-CH2OHCH2Cl) and 12 (2-CH3; 4-NO2; N-CH2OHCH2F), the fluorine atom had no influence on genotoxicity. This study contributes to the future search for new and safer prototypes and provide.


Assuntos
Dano ao DNA/efeitos dos fármacos , Nitroimidazóis/química , Nitroimidazóis/toxicidade , Salmonella/efeitos dos fármacos , Trypanosoma cruzi/efeitos dos fármacos , Animais , Ensaio Cometa , Relação Dose-Resposta a Droga , Camundongos , Testes de Mutagenicidade , Relação Estrutura-Atividade
4.
Mem. Inst. Oswaldo Cruz ; 97(1): 3-24, Jan. 2002. ilus
Artigo em Inglês | LILACS | ID: lil-306090

RESUMO

In this "Critical Review" we made a historical introduction of drugs assayed against Chagas disease beginning in 1912 with the works of Mayer and Rocha Lima up to the experimental use of nitrofurazone. In the beginning of the 70s, nifurtimox and benznidazole were introduced for clinical treatment, but results showed a great variability and there is still a controversy about their use for chronic cases. After the introduction of these nitroheterocycles only a few compounds were assayed in chagasic patients. The great advances in vector control in the South Cone countries, and the demonstration of parasite in chronic patients indicated the urgency to discuss the etiologic treatment during this phase, reinforcing the need to find drugs with more efficacy and less toxicity. We also review potential targets in the parasite and present a survey about new classes of synthetic and natural compounds studied after 1992/1993, with which we intend to give to the reader a general view about experimental studies in the area of the chemotherapy of Chagas disease, complementing the previous papers of Brener (1979) and De Castro (1993)


Assuntos
Humanos , Doença de Chagas , Tripanossomicidas
5.
Mem. Inst. Oswaldo Cruz ; 87(2): 209-15, abr.-jun. 1992. tab, ilus
Artigo em Inglês | LILACS | ID: lil-116307

RESUMO

Phenothiazines were observed to have a direct effect on Trypanosoma cruzi and on its in vitro interaction with host cells. They caused lysis of trypomastigotes (50 uM/24 h) and,to a lesser extent, epimastigote proliferation. Treatment of infected peritoneal macrophages with 12.5 uM chlorpromazine or triflupromazine inhibited the infection; this effect was found to be partially reversible if the drugs were removed after 24 h of treatment. At 60 uM, the drugs caused damage to amastigotes interiorized in heart muscle cells. However, the narrow margin of toxity between anti-trypanossomal activity and damage to host cells mitigates against in vivo investigation at the present time. Possible hypothesis for the mechanism of action of phenothiazines are discussed


Assuntos
Animais , Fenotiazinas/administração & dosagem , Interações Hospedeiro-Parasita , Trypanosoma cruzi/efeitos dos fármacos
6.
Biol. Res ; 25(1): 21-5, 1992. ilus, tab
Artigo em Inglês | LILACS | ID: lil-228630

RESUMO

The biosynthetic pigment from Chromobacterium violaceum BB-78, 1,3-dihydro-2H-indol-2-one and its derivatives exhibit biological activities such as antimicrobial action, low hemolytic effects on red blood cells and in vitro trypanocide activity. A relatively high cytotoxicity on V-79 hamster fibroblast cells of the biosynthetic pigment was found, although with the methylol derivative the toxicity was almost eliminated. The methylol derivative exhibited similar toxicity as Nifurtimox, a known, commercial trypanocide compound


Assuntos
Animais , Cricetinae , Antibacterianos/toxicidade , Chromobacterium/metabolismo , Hemólise , Indóis/toxicidade , Pigmentos Biológicos/toxicidade , Antibacterianos/isolamento & purificação , Bactérias/efeitos dos fármacos , Linhagem Celular , Sobrevivência Celular/efeitos dos fármacos , Chromobacterium/crescimento & desenvolvimento , Fibroblastos/efeitos dos fármacos , Indóis/isolamento & purificação , Testes de Sensibilidade Microbiana , Nifurtimox/toxicidade , Pigmentos Biológicos/isolamento & purificação , Trypanosoma cruzi/efeitos dos fármacos , Trypanosoma cruzi/crescimento & desenvolvimento
7.
Mem. Inst. Oswaldo Cruz ; 85(1): 95-9, jan.-mar. 1990. tab, ilus
Artigo em Inglês | LILACS | ID: lil-85175

RESUMO

Megazol (CL 64,855) a very effective drug in experimental infections by Trypanosoma cruzi, and also in in vitro assays with vertebrate forms of the parasite, had its parasite, had its activity upon macromolecule biosynthesis tested using tissue culture-derived amastigote forms. Megazol presented a drastic inhibition of [3H]-uridine incorporation, suggesting a selective activity upon protein synthesis. Comparing the three drugs, megazol was more potent than nifurtimox and benznidazole in inhibiting protein an DNA synthesis. Megazol showed a 91% of inhibition of [3H]-leucine incorporation whereas nifurtimox and benznidazole, 0% and 2%, respectively. These latter two drugs inhibited the incorporation of all the precursors tested at similar levels, but the concentration of benznidazole was always three times higher, suggesting different mechanisms of action or, more probably, a greater efficiency of the 5-nitrofuran derivate in relation to the 2-nitroimidazole. So, wes conclude that the mode of action of megazol is different from the ones of nifurtimox and benznidazole and that its primary effect is associated with an impairment of protein synthesis


Assuntos
Animais , Técnicas In Vitro , Nitroimidazóis/farmacologia , Proteínas/biossíntese , Tiadiazóis/farmacologia , Trypanosoma cruzi/efeitos dos fármacos , Benzimidazóis/farmacologia , Combinação de Medicamentos , Leucina/metabolismo , Nifurtimox/farmacologia
8.
Mem. Inst. Oswaldo Cruz ; 82(2): 209-18, Apr.-June 1987. tab, ilus
Artigo em Inglês | LILACS | ID: lil-59389

RESUMO

As açöes de megazol, nifurtimox, benznidazol e allopurinol sobre o T. cruzi foram investigadas, através de microscopia ótica e eletrônica, pela análise do efeito direto sobre formas amastigotas e tripomastigotas e do efeito sobre a interaçäo de cultura de célula muscular cardíaca com tripomastigotas sangüíneos. A proliferaçäo de amastigotas em meio Warren foi inibida de modo dose-dependente por megazol, nifurtimox e benznidazol. O tratamento de amastigotas (25-50 micronM/24h) e de tripomastigotas (25 micronM/24h) levou a várias alteraçöes ultraestruturais nos parasitas. Estas três drogas tiveram também um efeito potente no tratamento de culturas de células cardíacas infectadas, quando adicionadas desde o início da interaçäo ou após um ou três dias de infecçäo. Os parasitas interiorizados mostraram um padräo de alteraçöes ultraestruturais semelhante ao observado no tratamento direto de formas amastigotas. A cultura primária de célula muscular cardíaca mostrou ser um modelo adequado para o estudo de drogas sobre formas intracelulares de T. cruzi e o ensaio de proliferaçäo de amastigotas em meio axênico, indicado para uma triagem inicial de drogas. Estes parâmetros nos parecem muito confiáveis para uma investigaçäo sistemática do mecanismo de açäo de drogas


Assuntos
Animais , Alopurinol/farmacologia , Benzimidazóis/farmacologia , Técnicas In Vitro , Miocárdio/citologia , Nifurtimox/farmacologia , Trypanosoma cruzi/efeitos dos fármacos , Miocárdio/ultraestrutura , Trypanosoma cruzi/ultraestrutura
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...